We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

Financial Information


Financial Statement 2020 of NLS Pharmaceutics AG
Condensed Balance Sheets as of June 30, 2020 and December 31, 2019 (unaudited)
Condensed Statements of Operations and Comprehensive Loss for the Six Months Ended June 30, 2020 and 2019 (unaudited)
Condensed Statement of Changes in Shareholders’ Deficit for the Six Months Ended June 30, 2020 and 2019 (unaudited)
Condensed Statements of Cash Flows for the Six Months Ended June 30, 2020 and 2019 (unaudited)
Notes to Unaudited Condensed Financial Statements